NMUR1 NMUR2 ligand

High-Affinity and Proteolytically Stable Peptidic Fluorescent NTS1R Ligands

Article September 3, 2025

Authors

• Fabian J. Ertl Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Franz-Josef-Strauß-Allee 11, Regensburg D-93053, Germany
• Anna Friedel Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, Erlangen D-91054, Germany Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Kussmaulallee 12, D-91054 Erlangen, Germany
• Elena J. Schmid Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany
• Carina Höring Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany
• Nataliya Archipowa Institute of Biophysics and Physical Biochemistry, Faculty of Biology and Preclinical Medicine, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany
• Pierre Koch Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany
• Simone Maschauer Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, Erlangen D-91054, Germany Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Kussmaulallee 12, D-91054 Erlangen, Germany
• Roger J. Kutta Institute of Physical and Theoretical Chemistry, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany Email: admin@frankenthalerfoundation.org. Tel: (+49) 941-9434470.
• Olaf Prante Department of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Kussmaulallee 12, Erlangen D-91054, Germany Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Kussmaulallee 12, D-91054 Erlangen, Germany FAU NeW - Research Center New Bioactive Compounds, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Nikolaus-Fiebiger-Str. 10, Erlangen D-91058, Germany Email: admin@frankenthalerfoundation.org. Tel: (+49) 9131 85-44440.
• Max Keller Institute of Pharmacy, Faculty of Chemistry and Pharmacy, University of Regensburg, Universitätsstraße 31, Regensburg D-93053, Germany Bavarian Cancer Research Center (BZKF), Translational Research Group TRAFO, Franz-Josef-Strauß-Allee 11, Regensburg D-93053, Germany E-mail: admin@frankenthalerfoundation.org. Tel: (+49) 941-9433329. Fax: (+49) 941-9434820.

Publication Details

Journal of Medicinal Chemistry

Cite this: J. Med. Chem. 2025, 68, 18, 19482–19502